Holen Sie sich die Stockscreener-App
2.37
2.47%
-0.06
Schlusskurs vom Vortag:
$2.43
Offen:
$2.4
24-Stunden-Volumen:
5.94M
Relative Volume:
0.68
Marktkapitalisierung:
$715.52M
Einnahmen:
$188.87M
Nettoeinkommen (Verlust:
$-400.38M
KGV:
-1.58
EPS:
-1.5
Netto-Cashflow:
$-260.90M
1W Leistung:
-2.47%
1M Leistung:
+34.66%
6M Leistung:
+104.31%
1J Leistung:
+1.28%
1-Tages-Spanne:
$2.33
$2.47
1-Wochen-Bereich:
$2.30
$2.58
52-Wochen-Spanne:
$0.8511
$2.725
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
Firmenname
Pacific Biosciences Of California Inc
Sektor
Branche
Telefon
650-521-8000
Adresse
1305 O'BRIEN DRIVE, MENLO PARK, CA
Vergleichen Sie PACB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.37 | 733.64M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-11 | Herabstufung | UBS | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-04-18 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-17 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-31 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-06-30 | Eingeleitet | Goldman | Buy |
| 2023-05-10 | Eingeleitet | Barclays | Equal Weight |
| 2023-03-31 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2023-01-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-03-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-15 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | Eingeleitet | Cowen | Outperform |
| 2017-11-03 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | Herabstufung | CL King | Buy → Neutral |
| 2016-11-03 | Bestätigt | Cantor Fitzgerald | Buy |
| 2016-06-27 | Eingeleitet | CL King | Buy |
| 2016-04-15 | Eingeleitet | First Analysis Sec | Overweight |
| 2016-02-04 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | Bestätigt | Cantor Fitzgerald | Buy |
| 2015-10-23 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-02-04 | Bestätigt | Maxim Group | Buy |
| 2013-09-26 | Bestätigt | Maxim Group | Buy |
| 2013-01-14 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
Aug Swings: How Pacific Biosciences of California Inc stock reacts to Fed rate cutsJuly 2025 Breakouts & Fast Moving Stock Trade Plans - BỘ NỘI VỤ
EPS Watch: How Pacific Biosciences of California Inc stock valuations compare to rivalsStop Loss & Reliable Trade Execution Plans - BỘ NỘI VỤ
Pacific Biosciences of California Inc Stock Analysis and ForecastOptions Trading Strategies & Affordable Market Strategies - earlytimes.in
Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S Is Still On The Mark Following 26% Share Price Bounce - simplywall.st
Geode Capital Management LLC Increases Position in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Is Pacific Biosciences of California Inc. stock oversold or undervaluedJuly 2025 Rallies & Safe Swing Trade Setup Alerts - Newser
How Pacific Biosciences of California Inc. (P09) stock reacts to Fed tighteningEarnings Overview Summary & Weekly Top Stock Performers List - Newser
Is Pacific Biosciences of California Inc. (P09) stock undervalued historicallyWeekly Trend Recap & Community Trade Idea Sharing Platform - Newser
Will Pacific Biosciences of California Inc. (P09) stock beat revenue estimates2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Why PacBio (PACB) Stock Is Up Today - TradingView
Pacific Biosciences (PACB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Pacific Biosciences of California advances RNA sequencing in lung cancer research - Traders Union
Buy Signal: Will Pacific Biosciences of California Inc stock maintain dividend yieldJuly 2025 Price Swings & AI Forecasted Entry and Exit Points - BỘ NỘI VỤ
Does Pacific Biosciences of California Inc. (P09) stock trade below intrinsic valueMarket Risk Summary & Fast Moving Market Watchlists - Newser
Why Pacific Biosciences of California Inc. (P09) stock remains top rated2025 Earnings Impact & Fast Moving Trade Plans - Newser
How higher bond yields impact Pacific Biosciences of California Inc. (P09) stockJuly 2025 Market Mood & Safe Swing Trade Setups - Newser
XTX Topco Ltd Has $1.18 Million Stock Holdings in Pacific Biosciences of California, Inc. $PACB - MarketBeat
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference - marketscreener.com
PacBio (NASDAQ: PACB) schedules fireside chat at Piper Sandler 37th Annual Healthcare Conference - Stock Titan
Is Pacific Biosciences of California Inc. stock safe for conservative investorsMarket Activity Summary & Low Drawdown Investment Strategies - moha.gov.vn
How Recent Moves Are Rewriting the Story for PacBio Amid Shifting Analyst Sentiment - Yahoo Finance
Pacific Biosciences of California Insiders Made A Wise Decision By Selling US$864k Worth Of Stock - simplywall.st
Pullback Watch: Is Pacific Biosciences of California Inc. stock cheap compared to fundamentalsPortfolio Value Report & Real-Time Stock Entry Alerts - moha.gov.vn
Pacific Biosciences of California, Inc.Common Stock (NQ: PACB - Markets Financial Content
How risky is Pacific Biosciences of California Inc. stock now2025 EndofYear Setup & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
PACB Shares Climb as Market Adjusts to New Forecasts - timothysykes.com
Pacific Biosciences of California, Inc. $PACB Shares Sold by Edmond DE Rothschild Holding S.A. - MarketBeat
Pacific Biosciences of California: HiFi sequencing resolves genome complexities - Traders Union
Pacific Biosciences stock delivers 70% return after InvestingPro’s undervalued call By Investing.com - Investing.com Australia
PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - Finviz
PacBio Gains Traction with New Sequel II CNDx Approval in China - StocksToTrade
PacBio’s Strategic Steps: China’s Approval and HiFi Sequencing Insights Boost Confidence - timothysykes.com
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
What analysts say about Pacific Biosciences of California Inc P09 stockRetail Trading Trends & Low Entry Cost Capital - earlytimes.in
PacBio Stock May Gain Following the Collaborated Launch of GutID - MSN
What analysts say about Pacific Biosciences of California Inc stock - earlytimes.in
Can Dev Information Technology Limited Outperform Peers After Recent PullbackMarket Depth Overview & Low Risk Investment Tips - earlytimes.in
PacBio Stock Soars: Time to Dive In? - StocksToTrade
Pacific Biosciences of California launches HiFi guide to enhance lab workflows - Traders Union
PacBio’s Regulatory Triumph in China Fuels Market Optimism - timothysykes.com
PacBio’s New Regulatory Approval Fuels Expansion Hopes - timothysykes.com
Pacific Biosciences partners with SPT Labtech to enhance automation - Traders Union
Will Pacific Biosciences of California Inc. stock split again soon2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Will Pacific Biosciences of California Inc. (P09) stock announce special dividendWeekly Trend Report & Daily Chart Pattern Signals - newser.com
Is Pacific Biosciences of California Inc. stock ready for a breakoutProfit Target & Low Risk High Win Rate Stock Picks - newser.com
Price to cash flow ratio of Pacific Biosciences of California, Inc. – HAM:P09 - TradingView
Finanzdaten der Pacific Biosciences Of California Inc-Aktie (PACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):